The effectiveness of trabeculoplasmy in lowering intraocular pressure (IOP) in glaucoma patients was determined. A longitudinal study was carried out in 10 patients with open-angle glaucoma that underwent trabeculoplasmy. The postoperative results Of IOP, visual acuity (VA) and the occurrence of complications were evaluated at 24 hours, one week, 3, 6, 9 and 12 months. 10 surgeries were performed (10 eyes, 10 patients). Preoperative average IOP was 32.5mmHg and preoperative VA was 0.5. At one year the average IOP was 10.10 mmHg and the average VA was 0.7, both values were significant (p<0.001, p=0.019 respectively). Trabeculoplasmy may be effective technique in the treatment of glaucoma, providing a decrease and maintenance of IOP within normal limits after one year of follow-up.
Gyrus atrophy is a rare autosomal recessive hereditary disease secondary to a mutation of the OAT gene on chromosome 10 which results in a deficiency of the mitochondrial enzyme ornithine aminotransferase that causes a 20-fold increase in serum concentrations of the amino acid ornithine. The disease is characterized by atrophic choroid and retinal patches that begin in the peripheral retina in the first decade and later spread centrally to the macular area, causing cystic changes and posterior subcapsular cataracts.
The clinical picture is characterized by night blindness, constriction of the visual field and finally decreased central vision and blindness. In this article, we present the case of a 53-year-old woman with no significant hereditary antecedents who presented a decrease in visual acuity after several months of evolution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.